About Brenig Therapeutics
Brenig Therapeutics is a private company based in Dover, Delaware, incorporated in 2021 in Delaware. It has reported $30,000,000 raised in one offering on Form D since July 2024. Its chief executive is Nikolay Savchuk.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2024 | Jul 30, 2024 | $30,000,000of $65.0M target | 6 | $5.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Brenig Therapeutics's Form D filed Jul 30, 2024.
KG
Keno Gutierrez
Director
ID
Iain Dukes
Executive officer and director
EM
Edward Mathers
Director
NS
Nikolay Savchuk
Chief Executive Officer and director
MC
Michele Cucullu
Director